Excipients. UMAN shall utilise only excipients defined in the Master Manufacturing Document. Excipients shall either comply with the most recent Pharmacopoeia monograph (EP and USP) or UMAN’s Specifications where such excipients are not included in a Pharmacopoeia monograph. In all cases, UMAN shall supply to CLIENT a control copy of the Specifications of each excipient for review and approval. UMAN shall source excipients from reputable companies.
Appears in 2 contracts
Sources: Tech Transfer, Manufacturing and Supply Agreement (RedHill Biopharma Ltd.), Tech Transfer, Manufacturing and Supply Agreement (RedHill Biopharma Ltd.)